Mukka Proteins Ltd

Mukka Proteins Limited announced the allotment of 20,00,000 convertible warrants on a preferential basis to 15 non-promoter investors for a total consideration of Rs 47 crore. The warrants were issued at a price of Rs 23.50 per warrant, with investors paying an upfront subscription amount of Rs 5.88 per warrant, according to a regulatory filing. Each warrant allows the holder to subscribe for one equity share within 18 months.

Mukka Proteins Limited announced that its board approved a strategic investment of up to Rs 13,19,40,000 in Shipwaves Online Limited, a digital freight forwarding and enterprise SaaS solutions provider, acquiring 2,93,20,000 equity shares at Rs 4.50 per share, resulting in a 16.77% stake. The acquisition, expected to be completed by March 31, 2027, is considered a related party transaction as Mukka Proteins Limited is a promoter group entity of Shipwaves Online Limited, and is intended to leverage potential business synergies in logistics.

Mukka Proteins Ltd share price slipped 1% to Rs 23.79 after the company's net profit dropped 12.78% to Rs 18.63 crore, while revenue from operations gained significantly 29.05% to Rs 474.8 crore in Q2FY26 over Q1FY26. The market capitalization of Animal Feed industry group stocks on BSE stood at Rs 30763.81 crore, jumping 21.78%. It has softened by 3.54% over last one week and tumbled 21.98% in last one month while the market capitalization of Mukka Proteins Ltd has marginally improved by 3.93% and 0.67% in the same period respectively. Profit before tax (PBT) of Mukka Proteins Ltd stood at Rs 27.37 crore in Q2 FY26, expanding by 1059.75% year-on-year, and declining 5.26% quarter-on-quarter. EBITDA came in at Rs 46 crore, surging by 286.91% YoY and rallying 148.34% sequentially. Total expenses surged 26.88% to Rs 446.47 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 391.98 crore, posting a minor increase of 4.40% YoY, while employee benefits expense was at Rs 16.34 crore, soaring 24.45% YoY. For the TTM ended FY26, revenue from operations slumped by 26.98% to Rs 980.03 crore, while net profit tumbled by 35.27% to Rs 48.1 crore, compared to previous TTM. EBITDA surged by 8936% to Rs 79.76 crore, and PBT plunged by 31.09% to Rs 60.27 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 111.93 crore in FY26, as against Rs 150.41 crore in FY25. Mukka Proteins Ltd nosedived by 11.95% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.04% during the same period.

Mukka Proteins Limited announced that its board approved the re-appointment of Karkala Shankar Balachandra Rao, Hamad Bava, and Narendra Surendra Kamath as Non-Executive Independent Directors for a second term of five years, commencing January 15, 2027, and ending January 14, 2032, subject to shareholder approval. Additionally, the board re-appointed Kalandan Mohammed Haris as Managing Director and Chief Executive Officer for a further five years, effective January 20, 2027, to January 19, 2032, and re-appointed Kalandan Mohammed Althaf as Whole-Time Director and Chief Financial Officer and Kalandan Mohammad Arif as Whole-Time Director and Chief Operating Officer, both for five-year terms starting January 20, 2027.

Mukka Proteins Limited announced that its board approved a strategic investment of up to Rs 64,92,500 to acquire a 25.98% stake in Swachha Eco Solutions Private Limited, which is involved in the collection, treatment, and disposal of all types of waste, with the acquisition expected to be completed by December 31, 2026.

Mukka Proteins Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and three months period ended June 30, 2026, according to a regulatory filing. The trading window for dealing in the company's securities will be closed from Wednesday, July 1, 2026, until 48 hours after the results are declared for designated persons and their immediate relatives.

Mukka Proteins will hold a meeting of the Board of Directors of the Company on 12 June 2026.

Net profit of Mukka Proteins rose 51.73% to Rs 20.62 crore in the quarter ended March 2026 as against Rs 13.59 crore during the previous quarter ended March 2025. Sales declined 1.17% to Rs 367.92 crore in the quarter ended March 2026 as against Rs 372.26 crore during the previous quarter ended March 2025. For the full year,net profit rose 12.05% to Rs 52.06 crore in the year ended March 2026 as against Rs 46.46 crore during the previous year ended March 2025. Sales rose 43.21% to Rs 1403.52 crore in the year ended March 2026 as against Rs 980.03 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales367.92372.26 -1 1403.52980.03 43 OPM %9.207.81 -8.169.68 - PBDT34.0122.92 48 91.7473.82 24 PBT28.8920.10 44 75.1460.27 25 NP20.6213.59 52 52.0646.46 12 Powered by Capital Market - Live

Mukka Proteins will hold a meeting of the Board of Directors of the Company on 15 May 2026.

Net profit of Mukka Proteins declined 9.56% to Rs 23.75 crore in the quarter ended December 2025 as against Rs 26.26 crore during the previous quarter ended December 2024. Sales rose 114.26% to Rs 634.64 crore in the quarter ended December 2025 as against Rs 296.20 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales634.64296.20 114 OPM %7.1613.96 - PBDT38.6536.77 5 PBT34.6232.97 5 NP23.7526.26 -10 Powered by Capital Market - Live